Product Program year 2021 Source: CMS Open Payments

Flulaval Quadrivalent

Biological Vaccines

NDC 19515-818-52

Open in the dashboard

General payments

$11,180

708 payments

Research payments

$0

0 payments

Through program year 2021, $11,180 in general payments and $0 in research payments were reported against Flulaval Quadrivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $11,180 708

Breakdown

Who paid General payments · program year 2021
  1. GlaxoSmithKline, LLC. $11,180 708 payments
Top recipients General payments · program year 2021
  1. Joseph Segapeli Pediatrics · El Paso, TX $103 <1% · 7 payments
  2. Brent Thomason Family Medicine · Evansville, IN $76 <1% · 3 payments
  3. Kyle Lemond Family Medicine · Evansville, IN $76 <1% · 3 payments
  4. Paul Chlpka Pediatrics · Sharon, PA $60 <1% · 3 payments
  5. Valerie Weyand Nurse Practitioner, Pediatrics · Sharon, PA $60 <1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Pediatrics $3,390 31% · 169 practitioners
  2. Family Medicine $1,945 18% · 104 practitioners
  3. Internal Medicine $1,437 13% · 80 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $836 8% · 49 practitioners
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $719 7% · 34 practitioners

The top 5 of 37 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Pennsylvania $2,439 22% · 129 recipients
  2. New York $1,853 17% · 94 recipients
  3. Texas $1,364 12% · 74 recipients
  4. Indiana $1,078 10% · 37 recipients
  5. Missouri $838 7% · 40 recipients

The top 5 of 28 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

708 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record